About Still Velocity Inc.
Still Velocity designs computationally novel synthetic protein excipients to stabilize biologics at ambient temperatures, aiming to eliminate reliance on the pharmaceutical cold chain and improve global access to life-saving therapeutics.
Computational protein design using AI and molecular dynamics simulationDesign of synthetic vitrification proteins for ambient-temperature biologicsExperimental validation of protein candidates through contract research organizationsDevelopment of protective bioglasses to preserve biological cargo during desiccationPatent protection for computational design methodology and synthetic protein compositions
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to Still Velocity Inc. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.